C-reactive Protein in the Differentiation of Pyometra From Cystic Endometrial Hyperplasia/Mucometra in Dogs

Hematological parameters, plasma C-reactive protein (CRP), and tumor necrosis factor αwere analyzed in 64 dogs with a presumptive diagnosis of pyometra. Final diagnosis (i.e., pyometra or cystic endometrial hyperplasia [CEH]) was determined by histopathology. As a single test, the percentage of band neutrophils had the highest sensitivity in the prediction of pyometra (sensitivity, 94%). The combination of percentage of bands and CRP had the highest sensitivity (97.7%; specificity, 75%) in predicting the presence of pyometra. The most common clinical signs noted in the study were vaginal discharge, polyuria, polydipsia, lethargy, and gastrointestinal signs. A combination of three or more of these clinical signs was significantly associated with pyometra.

Download Full-text

Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade

Journal of Indian Society of Periodontology ◽

10.4103/jisp.jisp_77_19 ◽

2019 ◽

Vol 23 (6) ◽

pp. 511 ◽

Cited By ~ 1

Author(s):

WellingtonFrancisco Rodrigues ◽

CamilaBotelho Miguel ◽

JavierEmilio Lazo-Chica ◽

CarlosAntônio Trindade da Silva ◽

CarlosUeira Vieira ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Hematological Parameters ◽

Adrenergic Blockade ◽

C Reactive Protein ◽

Reactive Protein ◽

Factor Α ◽

Necrosis Factor ◽

Experimental Periodontal Disease

Download Full-text

Abstract #800: Effects of Atorvastatin and Candesartan on Inflammatory Cytokines Interferon-γ, Tumor Necrosis Factor-α, Interleukin-6, and C-Reactive Protein in Diabetic Patients with Hypertension, Hyperlipidemia, and Cardiac Hypertrophy

Endocrine Practice ◽

10.1016/s1530-891x(20)43653-5 ◽

2005 ◽

Vol 11 ◽

pp. 17-18

Author(s):

Stanley Andrew Tan ◽

Linda Giles Tan

Keyword(s):

Tumor Necrosis Factor ◽

Inflammatory Cytokines ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Interferon Γ ◽

Diabetic Patients ◽

C Reactive Protein ◽

Reactive Protein ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Abstract #58: Synergistic Effects of Simvastatin and Pioglitazone on Inflammatory Cytokines Interferon-gamma, Tumor Necrosis Factor-alpha, Interleukin-6 and C-reactive Protein in Diabetic Patients with Hyperlipidemia and Coronary Artery Disease

Endocrine Practice ◽

10.1016/s1530-891x(20)46337-2 ◽

2004 ◽

Vol 10 ◽

pp. 21

Author(s):

Stanley A. Tan ◽

Linda G. Tan

Keyword(s):

Coronary Artery Disease ◽

Tumor Necrosis ◽

Synergistic Effects ◽

Diabetic Patients ◽

C Reactive Protein ◽

Necrosis Factor Alpha ◽

Reactive Protein ◽

Factor Alpha ◽

Artery Disease ◽

Necrosis Factor

Download Full-text

Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa

Cytokine ◽

10.1016/j.cyto.2021.155585 ◽

2021 ◽

Vol 144 ◽

pp. 155585

Author(s):

Gonca Saraç Öztürk ◽

Tülin Ergun ◽

İrem Peker Eyüboğlu ◽

Mustafa Akkiprik

Keyword(s):

Tumor Necrosis Factor ◽

Hidradenitis Suppurativa ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

High Sensitivity ◽

C Reactive Protein ◽

Reactive Protein ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2015.02.004 ◽

2015 ◽

Vol 72 (5) ◽

pp. 917-919 ◽

Cited By ~ 5

Author(s):

Jashin J. Wu ◽

Christopher G. Rowan ◽

Judith D. Bebchuk ◽

Mary S. Anthony

Keyword(s):

Rheumatoid Arthritis ◽

Blood Pressure ◽

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitor ◽

C Reactive Protein ◽

Reactive Protein ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Serum Levels of Anticyclic Citrullinated Peptide Antibodies, Interleukin-6, Tumor Necrosis Factor-α, and C-Reactive Protein Are Associated with Increased Carotid Intima-Media Thickness: A Cross-Sectional Analysis of a Cohort of Rheumatoid Arthritis Patients without Cardiovascular Risk Factors

BioMed Research International ◽

10.1155/2015/342649 ◽

2015 ◽

Vol 2015 ◽

pp. 1-10 ◽

Cited By ~ 9

Author(s):

Mónica Vázquez-Del Mercado ◽

Lourdes Nuñez-Atahualpa ◽

Mauricio Figueroa-Sánchez ◽

Eduardo Gómez-Bañuelos ◽

Alberto Daniel Rocha-Muñoz ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cardiovascular Risk ◽

Cardiovascular Events ◽

Tumor Necrosis ◽

Intima Media Thickness ◽

Carotid Intima Media Thickness ◽

C Reactive Protein ◽

Reactive Protein ◽

Citrullinated Peptide ◽

Necrosis Factor

The main cause of death in rheumatoid arthritis (RA) is cardiovascular events. We evaluated the relationship of anticyclic citrullinated peptide (anti-CCP) antibody levels with increased carotid intima-media thickness (cIMT) in RA patients.Methods. Forty-five anti-CCP positive and 37 anti-CCP negative RA patients, and 62 healthy controls (HC) were studied. All groups were assessed for atherogenic index of plasma (AIP) and cIMT. Anti-CCP, C-reactive protein (CRP), and levels of tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6) were measured by enzyme-linked immunosorbent assay (ELISA).Results. The anti-CCP positive RA patients showed increased cIMT compared to HC and anti-CCP negative (P<0.001). Anti-CCP positive versus anti-CCP negative RA patients, had increased AIP, TNFαand IL-6 (P<0.01), and lower levels of high density lipoprotein cholesterol (HDL-c) (P=0.02). The cIMT correlated with levels of anti-CCP (r=0.513,P=0.001), CRP (r=0.799,P<0.001), TNFα(r=0.642,P=0.001), and IL-6 (r=0.751,P<0.001). In multiple regression analysis, cIMT was associated with CRP (P<0.001) and anti-CCP levels (P=0.03).Conclusions. Levels of anti-CCP and CRP are associated with increased cIMT and cardiovascular risk supporting a clinical role of the measurement of cIMT in RA in predicting and preventing cardiovascular events.

Download Full-text